ATOSSA THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ATOSSA THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $100.00K.
- ATOSSA THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $204.00K.
- ATOSSA THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2020-09-30 was $4.34M.
- ATOSSA THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2020-06-30 was $347.63K.
- ATOSSA THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2024 was $3.67M.
- ATOSSA THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2020 was $4.67M.
- ATOSSA THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2017 was $829.68K, a 82.33% decline from fiscal 2016.
- ATOSSA THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2016 was $4.70M, a 48.45% decline from fiscal 2015.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-12-31 | $3.67M 10-K · filed 2026-03-25 | |
| 2024-06-30 | $100.00K 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $204.00K 10-Q · filed 2025-11-12 | |
| 2020-12-31 | $4.67M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $4.34M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $347.63K 10-Q · filed 2021-11-15 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2018-11-14 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $829.68K 10-K · filed 2018-03-08 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | |
| 2016-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2017-03-21 | $4.70M 10-K/A · filed 2017-03-21 |
| 2016-09-30 | $2.56M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-03-21 | |
| 2015-12-31 | $9.11M 10-K/A · filed 2017-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |